Literature DB >> 3865369

A transgenic mouse model of the chronic hepatitis B surface antigen carrier state.

F V Chisari, C A Pinkert, D R Milich, P Filippi, A McLachlan, R D Palmiter, R L Brinster.   

Abstract

In an attempt to establish a model of the healthy carrier state in hepatitis B virus (HBV) infections, transgenic mice expressing HBV genes were produced. Fertilized one-cell eggs were microinjected with subgenomic fragments of HBV DNA containing the coding regions for the HBV surface antigen (HBsAg) and pre-S and X antigens. Either the normal (HBV) or metallothionein promoters were used to obtain expression of the HBV genes. There was no evidence of viral replication or tissue pathology. The integrated HBV DNA sequences were inherited in a normal Mendelian fashion. Three of 16 transgenic mice expressed HBV-encoded gene products to which they were immunologically tolerant. Expression was not tissue specific and may be influenced by the genomic integration site and cellular factors. Both HBsAg and pre-S antigen were detectable within the cytoplasm of hepatocytes and renal tubular epithelial cells. High serum concentrations of HBsAg were detectable and the secreted product appeared authentic as judged by mean density, morphology, mean particle diameter, polypeptide composition, and antigenicity. The absence of tissue pathology in these immunologically tolerant animals supports the hypothesis that cellular injury under these conditions is not a direct consequence of expression of the pre-S or HBs regions of the HBV genome.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3865369     DOI: 10.1126/science.3865369

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  94 in total

Review 1.  Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B.

Authors:  F V Chisari
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

2.  Establishment of transgenic mouse harboring hepatitis B virus (adr subtype) genomes.

Authors:  Y P Hu; W J Hu; W C Zheng; J X Li; D S Dai; X M Wang; S Z Zhang; H Y Yu; W Sun; G R Hao
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

3.  Tissue preferential expression of the hepatitis B virus (HBV) surface antigen gene in two lines of HBV transgenic mice.

Authors:  R D Burk; J A DeLoia; M K elAwady; J D Gearhart
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

Review 4.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 5.  Hepatitis B virus-induced oncogenesis.

Authors:  Joachim Lupberger; Eberhard Hildt
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

6.  Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site.

Authors:  T Heise; L G Guidotti; F V Chisari
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  Separate origins of hepatitis B virus surface antigen-negative foci and hepatocellular carcinomas in transgenic HBsAg (alb/psx) mice.

Authors:  Dana R Crawford; Stephanie Ostrowski; Dilip Vakharia; Zoran Ilic; Stewart Sell
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

8.  Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma.

Authors:  T M Hagen; S Huang; J Curnutte; P Fowler; V Martinez; C M Wehr; B N Ames; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

Review 9.  Mouse models for liver cancer.

Authors:  Latifa Bakiri; Erwin F Wagner
Journal:  Mol Oncol       Date:  2013-02-05       Impact factor: 6.603

10.  High prevalence of hepatitis B virus pre-s mutant in countries where it is endemic and its relationship with genotype and chronicity.

Authors:  Tran Thien-Tuan Huy; Hiroshi Ushijima; Khin Maung Win; Pairoj Luengrojanakul; Pradeep Krishna Shrestha; Zhao-Hua Zhong; Andrei V Smirnov; Teresa Casanovas Taltavull; Tetsutaro Sata; Kenji Abe
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.